Exploring ondansetron as potential therapy for opioid-exposed infants

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

As the opioid crisis continues, the number of babies born with neonatal opioid withdrawal syndrome (NOWS) – a condition that affects infants whose mothers used opioids during pregnancy – has risen 5-fold over the past 20 years.